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Abstract
DNA sequence amplification is a phenomenon that occurs predictably at defined stages during normal development in
some organisms. Developmental gene amplification was first described in amphibians during gametogenesis and has not
yet been described in humans. To date gene amplification in humans is a hallmark of many tumors. We used array-CGH
(comparative genomic hybridization) and FISH (fluorescence in situ hybridization) to discover gene amplifications during in
vitro differentiation of human neural progenitor cells. Here we report a complex gene amplification pattern two and five
days after induction of differentiation of human neural progenitor cells. We identified several amplified genes in neural
progenitor cells that are known to be amplified in malignant tumors. There is also a striking overlap of amplified
chromosomal regions between differentiating neural progenitor cells and malignant tumor cells derived from astrocytes.
Gene amplifications in normal human cells as physiological process has not been reported yet and may bear resemblance to
developmental gene amplifications in amphibians and insects.
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Introduction
DNA sequence amplification describes any event that increases
the copy number of a gene per haploid genome above the
number that is characteristic for that organism [1]. Gene
amplification has been reported for defined stages during normal
development of Xenopus laevis, Drosophila melanogaster, Sciara
coprophila,a n dTetrahymena thermophila [1–4]. The ability of a cell
to amplify genes represents an alternative to the problem of how
best to meet a short and sharp, but heavy demand for a stage-
specific protein [1]. This amplification process is spatially and
temporally restricted on specific DNA regions and narrow
windows of developmental time [4]. In humans, gene amplifica-
tion has only been found in multidrug resistant cells and in cancer
cells. The only circumstantial evidence for gene amplification in
normal mammalian cells stems from two studies on mouse
embryo cells with double minute chromosomes (DMs), that are
cytogenetic manifestations of gene amplification. One study
described DMs in cell lines derived from mouse fetus [5]. The
other study described DMs in 1% of serum free mouse embryo
(SFME) cells and an elevated frequency of DMs in cells grown in
medium containing fetal calf serum (FCS) [6]. SFME cells were
distributed from the American Type Culture Collection (ATCC)
as neural stem cell line. From today’s view, these SFME cells
were neural progenitor cells that are capable of differentiating
into astrocytes when grown in the presence of growth factor
TGF-ß or fetal calf serum (FCS). This hint for gene amplification
as physiological process in mammalian cells, specifically progen-
itor cells, prompted us to study gene amplification in normal
human neural progenitor cells (NHNP). These cells grow as
spheres and express b-III Tubulin (neuronal lineage) and GFAP
(astrocyte lineage) upon differentiation. Recent studies on various
human embryonic stem cells revealed genetic changes during
prolonged culture [7]. Whole-genome genotyping analysis of
NHNP cells created from NHNP primary cells at passage 20
were, however, still considered ‘‘normal’’ with a low number of
CNVs (copy number variations).200 kb (0–2 per line) [8,9].
Notably, NHNP cells used in this study were primary cells in
passage 1 [8].
The results of our genome-wide gene amplification analysis
during in vitro differentiation of normal human progenitor cells
revealed a complex amplification pattern after two and five days of
differentiation. Representative examples of amplified chromosom-
al regions were confirmed by fluorescence in situ hybridizations.
We further characterized those cells with amplifications using
immunofluorescence staining. We found a strong overlap of
amplified genes in neural progenitor cells undergoing differenti-
ation and amplified genes in malignant tumors derived from
astrocytes.
Results
Identification of gene amplifications using array-CGH
analysis
Differentiation of NHNP cells was induced by withdrawal of
EGF and bFGF and supplementation of brain derived neuro-
trophic factor (BDNF). The expression of Tubulin beta-3 chain
and GFAP was analyzed by immunofluorescence after 24 h
following differentiation induction. For amplification analysis
total DNA was isolated from undifferentiated NHNP sphere cells
and from NHNP cells differentiated for 24 h, 2 d and 5 d
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Amplified chromosomal regions after 2 d of
differentiation
Amplified chromosomal regions after 5 d of
differentiation Genes
Chromo-some start end
log2
ratio
size
(Mb) Chromo-some start end
log2
ratio
size
(Mb)
chr1 362499 3837499 0,194 3,48 chr1 362499 3837499 0,175 3,48
chr1 5612499 12612499 0,115 7,00 chr1 5662499 12187499 0,128 6,53 PHF13
chr1 151587499 155337499 0,125 3,75 chr1 14362499 46587499 0,103 32,23
chr1 151712499 155462499 0,161 3,75 HDGF
chr1 200612499 204962499 0,136 4,35 SOX13,MDM4
chr2 19937499 20737499 0,126 0,80 chr2 8462499 12112499 0,117 3,65 ID2
chr2 220037499 220312499 0,153 0,28 chr2 23412499 25337499 0,114 1,93
chr2 46937499 47712499 0,135 0,78
chr2 72912499 73337499 0,150 0,43
chr2 85237499 86737499 0,136 1,50
chr2 216662499 217312499 0,132 0,65
chr3 46637499 50112499 0,117 3,48 chr3 8137499 16762499 0,104 8,63
chr3 50137499 50687499 0,239 0,55 chr3 48212499 50712499 0,168 2,50
chr3 51912499 52862499 0,164 0,95 chr3 51962499 53312499 0,163 1,35
chr3 185087499 186037499 0,122 0,95 chr3 128537499 131287499 0,110 2,75
chr3 194887499 196812499 0,104 1,93 chr3 184787499 186012499 0,131 1,23
chr3 194962499 199378356 0,105 4,42
chr4 37499 9362499 0,103 9,33 chr4 637499 3737499 0,153 3,10
chr4 5812499 8537499 0,140 2,73
chr5 87499 1912499 0,120 1,83 chr5 87499 1912499 0,103 1,83 TERT
chr5 149512499 150037499 0,149 0,53 chr5 10187499 10812499 0,121 0,63
chr5 137487499 142112499 0,131 4,63
chr5 148562499 150537499 0,120 1,98 CAMK2A
chr6 111987499 112287499 0,150 0,30 chr6 2662499 4112499 0,139 1,45
chr6 40362499 44862499 0,100 4,50
chr7 137499 2987499 0,140 2,85
chr7 43962499 45087499 0,127 1,13
chr7 72012499 75887499 0,113 3,88
chr7 141837499 142212499 0,186 0,38
chr7 150237499 150737499 0,166 0,50
chr8 27162499 27587499 0,127 0,43 chr8 37237499 38987499 0,102 1,75
chr8 142112499 142612499 0,124 0,50 chr8 41562499 42312499 0,121 0,75
chr8 143087499 146257115 0,120 3,17 chr8 61687499 62237499 0,148 0,55
chr8 123612499 124637499 0,103 1,03
chr8 140612499 146257115 0,127 5,64
chr9 115812499 116412499 0,130 0,60 chr9 115787499 116412499 0,110 0,63
chr9 122237499 140235768 0,104 18,00 chr9 122112499 124162499 0,110 2,05
chr9 128112499 140162499 0,149 12,05
chr10 72962499 73787499 0,157 0,83 chr10 24837499 25287499 0,117 0,45
chr10 79237499 81362499 0,125 2,13 chr10 78837499 81037499 0,146 2,20
chr10 134437499 135087499 0,135 0,65 chr10 87812499 88812499 0,106 1,00
chr10 101912499 106112499 0,110 4,20
chr11 62499 4162499 0,112 4,10 chr11 62499 4162499 0,106 4,10
chr11 60737499 61387499 0,206 0,65 chr11 17162499 17612499 0,142 0,45
chr11 47112499 47587499 0,191 0,48
chr11 60187499 60712499 0,109 0,53
chr11 60987499 61537499 0,200 0,55
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Amplified chromosomal regions after 2 d of
differentiation
Amplified chromosomal regions after 5 d of
differentiation Genes
Chromo-some start end
log2
ratio
size
(Mb) Chromo-some start end
log2
ratio
size
(Mb)
chr11 61912499 62412499 0,205 0,50
chr11 63362499 63812499 0,258 0,45
chr11 63837499 64112499 0,140 0,28
chr11 64412499 64887499 0,145 0,48
chr11 65312499 66587499 0,174 1,28
chr12 6237499 7212499 0,136 0,98 chr12 6262499 7212499 0,174 0,95
chr12 123362499 123687499 0,213 0,33 chr12 47312499 53112499 0,112 5,80 HOXC6
chr12 123712499 124462499 0,110 0,75 chr12 54337499 56762499 0,147 2,43 CDK4, CYP27B1, KUB3
chr12 118937499 124487499 0,137 5,55 SCARB1, DIABLO
chr13 23412499 23812499 0,135 0,40
chr13 24362499 24687499 0,108 0,33
chr14 22062499 24037499 0,117 1,98 chr14 22062499 24137499 0,138 2,08
chr14 76412499 77062499 0,145 0,65
chr15 18862499 21212499 0,133 2,35 chr15 18537499 20062499 0,139 1,53
chr15 28237499 28662499 0,186 0,43 chr15 28237499 28637499 0,106 0,40
chr15 29212499 29537499 0,148 0,33 chr15 29187499 29462499 0,128 0,28
chr15 30237499 30612499 0,126 0,38 chr15 38062499 38537499 0,168 0,48
chr15 72112499 73037499 0,160 0,93 chr15 49987499 50362499 0,105 0,38
chr15 75687499 76137499 0,202 0,45 chr15 71787499 73387499 0,173 1,60
chr15 80387499 80862499 0,186 0,48 chr15 75562499 76162499 0,170 0,60
chr16 12499 1487499 0,221 1,48 chr16 87499 1362499 0,190 1,28
chr16 1512499 5012499 0,119 3,50 chr16 1512499 4937499 0,142 3,43 NUDT16L1
chr16 29487499 31512499 0,151 2,03 chr16 29487499 31487499 0,138 2,00
chr16 82487499 83737499 0,106 1,25 chr16 55437499 56687499 0,148 1,25
chr16 83762499 84337499 0,222 0,58 chr16 64662499 69387499 0,121 4,73
chr16 86587499 88707518 0,181 2,12 chr16 73762499 74137499 0,151 0,38
chr16 79962499 80287499 0,161 0,33
chr16 82487499 83712499 0,127 1,23
chr16 83737499 84412499 0,250 0,68 GINS2
chr16 85862499 88707518 0,162 2,85
chr17 12499 2937499 0,124 2,93 chr17 12499 2837499 0,136 2,83
chr17 6862499 8337499 0,139 1,48 chr17 7037499 8162499 0,202 1,13 TP53
chr17 16262499 18037499 0,144 1,78 chr17 16037499 19787499 0,138 3,75
chr17 22587499 24437499 0,101 1,85 chr17 23787499 24537499 0,182 0,75
chr17 33687499 36012499 0,119 2,33 chr17 31812499 41512499 0,126 9,70 C1QL1
chr17 36812499 40937499 0,122 4,13 chr17 42137499 46812499 0,118 4,68 ABCC3
chr17 41037499 41537499 0,104 0,50 chr17 62137499 62462499 0,179 0,33
chr17 46087499 46687499 0,113 0,60 chr17 67562499 78637061 0,151 11,07
chr17 67587499 76512499 0,126 8,93
chr17 76537499 76937499 0,291 0,40
chr17 76962499 78637061 0,149 1,67
chr18 54687499 54962499 0,126 0,28 chr18 33037499 33462499 0,103 0,43
chr18 75287499 76107311 0,104 0,82
chr19 212499 8487499 0,145 8,28 chr19 37499 8612499 0,172 8,58
chr19 9737499 19837499 0,131 10,10 chr19 9787499 14712499 0,153 4,93
chr19 49912499 50537499 0,199 0,63 chr19 15062499 20137499 0,153 5,08
chr19 37762499 47887499 0,101 10,13
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genome tiling arrays. Signal intensity data were extracted from
scanned images of each array using Roche NimbleGen
NimbleScan v2.6 software. After spatial correction, the Cy3
and Cy5 signal intensities were normalized using qspline
normalization. Following normalization a 106 window–averag-
ing step is applied. Window-averaging reduces the size of the
data and reduces the noise in the data. For amplification
detection we used the dynamic segMNT algorithm that identifies
segments by minimizing the squared error relative to the
segment means. To detect representative alterations and to
minimize the identification of random alterations, we extracted
segments with segment means greater 0.1 threshold and a size
greater than 250 kb. Chromosomal regions that revealed copy
number gains and match CNVs (copy number variations)
present in the Database of Genomic Variants available at
UCSC Genome Browser were excluded from further analysis.
While we did not detect amplified regions in NHNP cells at zero
time and 24 h after differentiation, we found numerous
chromosomal regions with copy number gains in NHNP cells
after 2 d and 5 d of differentiation. In total we found 66
amplified chromosome regions after 2 d of differentiation and 93
amplified chromosome regions after 5 d of differentiation
(Table 1). We also detected 9 deleted chromosome regions after
2 d of differentiation and 30 deleted chromosome regions after
5 d of differentiation. Whole genome profiles were presented in
Figure 1.
Confirmation of gene amplification of selected loci
Using array-CGH we identified amplified chromosome regions
in a mixed population of cells during in vitro differentiation. To
validate these results we used fluorescence in situ hybridization
(FISH) on loci with log2 ratios ranging from 0.126 to 0.250. We
analyzed one gene for each locus including 1q23.1 at 154.98 Mb
(HDGF), 1q32.1 at 202.35 Mb (SOX13), 12q14.1 at 56.43 Mb
(CDK4), at 56.44 (CYP27B1) and at 56.63 Mb (XRCC6BP1/
KUB3), 12q24.31 at 121.26 MB (DIABLO), 16q24.1 at 84.27 Mb
(GINS2), 17p13.1 at 7.52 Mb (TP53) and 17q21.31 at 40.4 Mb
(C1QL1). FISH analysis confirmed the amplifications for all loci
(Figure 2). Next we determined the amplification frequency
analyzing 150 nuclei per locus. We found an average amplifica-
tion frequency for GINS2 and CDK4 of 5% after 2 d of
differentiation, an amplification frequency for CYP27B1 of 3%
after 2 d of differentiation, an amplification frequency for SOX13,
C1QL1 and HDGF of 10% after 5 d of differentiation and an
amplification frequency for TP53 and DIABLO of 5% after 7 d of
differentiation. Both the copy number variation in cells with gene
amplification, and the absence of gene amplifications in many
cells, account for the low increase in log2 ratio in array-CGH
analysis.
As further validation step we compared the amplification event
between genes from two neighboring chromosome regions. Within
chromosome region 16q24.1 the log2 ratio values revealed an
increase of genomic sequences at 83.7–84.4 Mb. In the same
chromosome region, the log2 ratio values indicated a normal copy
number at 82 Mb (Figure 3A). FISH experiments revealed
amplification of the GINS2 gene that maps at 84.27 Mb, but no
amplification for CDH13 at 82 MB (Figure 3Bi). FISH analysis
also provided evidence for a large heterogeneity of amplifications
in neighboring cells. Figure 3Bii shows a nucleus with amplified
GINS2 fluorescence signals next to a nucleus with only 3 GINS2
specific fluorescence signals.
For further validation we analyzed chromosome region
12q14.1. For this region the log2 ratio values indicated an
increase of genomic sequences at 54–56.7 Mb (Figure 3C).
FISH confirmed not only the amplification of the CDK4 gene at
56.43 Mb and the adjacent XRCC6BP1/KUB3 gene at
56.63 Mb (Figure 3 Di) but also indicated the difference in
the localization of the amplified sequences between both genes.
While the CDK4 specific fluorescence signals were widely
spread, the XRCC6BP1/KUB3 s i g n a l sw e r em o r ef o c u s e d .
(Figure 3 D ii).
Characterization of cells with gene amplifications
We asked whether the identified amplification pattern was
different between cells that were still part of the sphere and cells
that migrated out of the sphere during the differentiation process.
By using simultaneous FISH and immunofluorescence (IF) we
analyzed the amplification status of selected genes and the
expression of the differentiation marker GFAP. After two or five
Table 1. Cont.
Amplified chromosomal regions after 2 d of
differentiation
Amplified chromosomal regions after 5 d of
differentiation Genes
Chromo-some start end
log2
ratio
size
(Mb) Chromo-some start end
log2
ratio
size
(Mb)
chr19 50012499 56212499 0,138 6,20 FUT1
chr20 59037499 62387499 0,162 3,35 chr20 20137499 20412499 0,142 0,28
chr20 24887499 25687499 0,110 0,80
chr20 29462499 36962499 0,115 7,50
chr20 59137499 62387499 0,161 3,25
chr21 42387499 43537499 0,139 1,15 chr21 41887499 44337499 0,112 2,45
chr22 18537499 18862499 0,357 0,33 chr22 14862499 30862499 0,117 16,00 RANBP1
chr22 33737499 49559126 0,108 15,82 chr22 33987499 49559126 0,127 15,57
Chromosome regions that overlap with gained chromosome regions of TCGA glioblastoma samples are indicated in bold. Likewise, genes that were used for FISH
analysis are indicated in bold. Examples of glioblastoma-amplified genes were included for chromosomal regions amplified after 5 d of differentiation. Start and end
point were according to NCBI36/HG18.
doi:10.1371/journal.pone.0037422.t001
Gene Amplification during Differentiation
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37422days of differentiation we found both NHNP cells with weak
GFAP staining close to the nucleus and NHNP cells with a strong
GFAP staining throughout the cytoplasm of the cell body and the
appendages. This staining pattern was reproducible in several
biological replicates and indicates different stages of the
differentiation process at the two time points.
While cells with strong GFAP expression showed a normal
copy number for all genes tested, e.g. CDK4 and GINS2, cells
with weak GFAP expression showed amplifications of CDK4 and
GINS2 after 2 d and 5 d (Figures 4 A, B). While cells with a
weak GFAP expression were localized in or near the sphere,
cells that had migrated out of the sphere revealed a stronger
expression of the differentiation marker GFAP and a differen-
tiated morphology of the cell body with typical appendages.
Similar results were obtained with immunofluorescence staining
using the differentiation marker Tubulin beta-3 chain. Notably,
after 11 days of differentiation we still found CDK4 amplification
in NHNP cells with weak Tubulin beta-3 chain expression
(Figure 4 C, D).
Discussion
SFME cells are non-tumorigenic and display characteristics of
progenitor cells of the central nervous system [10]. Addition of
FCS up-regulates GFAP expression indicating the capacity to
differentiate into astrocytes [10]. The SFME cell line had
undergone 96 population doublings in serum free medium and
revealed double minutes in one percent of the cells [6]. A higher
percentage of double minutes were detectable in SFME cells that
were capable of growing in FCS containing medium. This increase
in percentage of cells with double minutes under differentiation
promoting conditions prompted us to investigate gene amplifica-
tion during differentiation.
Figure 1. Whole chromosome plots. A genome-wide view of the 106window-averaged data at 25 kb resolution is displayed for NHNP cells at
day 0, day 1, day 2 and day 5 during differentiation.
doi:10.1371/journal.pone.0037422.g001
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were grown as spheres and that were capable of differentiating
into neurons and astrocytes. There is early evidence that cells
with glial morphology migrate out of the spheres as result of an
induced differentiation [11]. A more recent study reported
human NPCs (neural progenitor cells) that expressed both GFAP
and Tubulin beta-3 chain in the migration area 24 h after
differentiation induction [12]. NHNP sphere cells used in this
study revealed cells with glial morphology that migrated out of
the sphere a short time after differentiation induction. We were
able to confirm GFAP and Tubulin beta-3 chain expression in
the migration area 24 h after differentiation induction. In our
study gene amplifications appear to occur preferentially in cells
that still localize in or close to the sphere. From gene
amplification analysis in glioblastoma cells it is known that
amplifications can be lost [13]. In this study we can raise the
hypothesis that cells with amplifications die upon differentiation
or that differentiated cells have lost their amplifications. Further
investigations will be necessary to determine whether neural
progenitor cells show amplification as a prerequisite for differen-
tiation or whether the differentiation process is the prerequisite
for amplification.
Since small focal gains likely represent copy number
variations that are commonly found in the human genome,
we considered only loci larger than 250 kb. Our amplification
analysis after two and five days of in vitro differentiation revealed
a complex genome-wide amplification pattern with 66 or 93
amplified loci. The size of the amplified chromosome regions
was between 250 kb and more than 10 Mb. Array-CGH data
were carefully interpreted. We are aware that a gain in log2
ratio value of 0.25 can be regarded as gain of one copy. But
these calculations were only true when analyzing a homogenous
cell population. Here we analyzed a very complex cell
population with many cells in differing stages of differentiation.
Even after 7 d or 11 d of differentiation we still find cells with
amplifications and cells with a weak GFAP or Tubulin ß III
staining likely indicating early stages of the differentiation
process in these cells. It is very likely that we still missed
amplifications in other chromosomal regions by our array-CGH
approach because the number of cells with those amplifications
is too small or the level of amplification is not high enough for
detection by this means. This is further supported by the fact,
that in our array-CGH analysis CDK4 gene amplifications were
only detected after 5 d of differentiation. But FISH analysis on
NHNP cells differentiatedf o r2 da l r e a d yr e v e a l e dCDK4
amplifications as shown in Figure 2, 3.
Analysis of these chromosome regions revealed hundreds of
genes that were involved in this amplification process. Besides
amplifications, we also detected deletions that were mainly
localized in chromosome regions lacking genes or contain only
few genes. In contrast, amplified chromosome regions mainly
map within chromosome regions with a high gene density
(Figure 5).
As stated above, gene amplification is a hallmark of many
human tumors including brain tumors. Several chromosomal
regions amplified in neural progenitor cells contain genes that are
also amplified in glioblastoma including CDK4, SOX13, TERT,
ABCC3, RANBP1, MDM4, CAMK2A, ID2 and FUT1 [14–18]. In
Figure 2. FISH analysis of amplified loci. For each FISH analysis, a BAC or cosmid clone containing the indicated gene was Cy3-labelled (pink)
and hybridized against fixed NHNP cells that were differentiated for either 2, 5 or 7 days. Amplifications are shown for C1QL1 RP11-113A24 (5 days),
SOX13 RP11876H8 (5 days), HDGF RP11-66D17 (5 days), CYP27B1 cosmid (2 days), GINS2 RP11-118F19 (2 days), CDK4 RP11-571M6 (2 days), TP53 RP11-
1081A10 (7days), DIABLO RP11-568C23 (7 days). Nuclei were counterstained with DAPI. Size calibration bar=5 mm. Notably, the degree of
amplification various within each analysis due to the high heterogeneity of the amplifications in each cell population.
doi:10.1371/journal.pone.0037422.g002
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amplified in NHNP cells that were differentiated for 2 days and 5
days, and gained chromosome regions in 251 glioblastoma
deposited in the TCGA data collection [19].
Gene amplifications in normal human cells as physiological
process have not been reported yet. Since our in vitro study was
focused on a narrow time window of few days during the
differentiation process and since amplifications were found only in
a smaller number of cells, we would not expect to see readily
identifiable amplification events in human normal tissue. Further
light onto the amplification process will be shed by comparative
analyses of this process in other mammals to see if and to what
extent amplification can be found during cell differentiation in
other species.
Materials and Methods
Cell culture and differentiation
NHNP cells were obtained from Lonza (Verviers, Belgium) as
cryopreserved sphere culture and were cultivated in maintenance
medium (NPMM) containing EGF and bFGF for 24 h after
thawing. NHNP cells were primary cells in P1 established from
human embryonic brain (17WG, male and 18WG, sex unknown).
Spheres were not expanded or cultured after these initial 24 h.
Spheres were seeded on laminin-coated glass slides (autoclaved)
and allowed to attach to the surface for 5 minutes. Spheres were
differentiated using differentiation medium (NPDM) supplement-
ed with BDNF (25 ng/ml).
Figure 3. Detailed gene amplification analysis on human chromosome 16 and 12. Representative sections of log2 ratio profiles for
undifferentiated (0 d) NHNP cells and cells that were differentiated for 2 and 5 days. Base count is given on the x-axis and log2 ratio on the y-axis for
chromosome 16q24.1 (A) and 12q14.1 (C). Chromosomal localization of BAC probes used for FISH were indicated at the bottom of figures C and D. A
GINS2 specific BAC probe that was labeled in pink and a CDH13 specific BAC probe that was labeled in green were hybridized simultaneously against
fixed NHNP cells that were differentiated for 2 days. GINS2 amplification is indicated as pink speckled fluorescence signals whereas the neighboring
CDH13 gene shows only single copy fluorescence signals (Bi). Neighboring cells with and without GINS2 amplification are shown in Figure Bii. A CDK4
specific BAC probe that was labeled in pink and a XRCC6BP1/KUB3 specific BAC that was labeled in green were hybridized simultaneously against
NHNP cells that were differentiated for 2 days. CDK4 and KUB3 amplifications were detectable as cluster of pink and green speckled fluorescence
signals. CDK4 specific signals spread over a more extended area than the KUB3 specific signals (D). Nuclei were counterstained with DAPI (B). Size
calibration bar=5 mm.
doi:10.1371/journal.pone.0037422.g003
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Genomic DNA was extracted from cell cultures and normal
blood lymphocytes using NaCl/chloroform extraction. Control
genomic DNA was mixed from male and female healthy blood
lymphocytes to minimize for normal CNV detection.
Array preparation, hybridization and detection
NimbleGen 3x720K whole genome array hybridization was
done using the certified full service of NimbleGen 3x720K human
whole genome array hybridization from ImaGenes Berlin,
Germany. Detailed information on data analysis is described at
http://www.nimblegen.com/products/cgh/wgt/human/3x720k/
index.html. Array-CGH analysis was performed on primary
NHNP cells at time point zero, and after 1 d, 2 d and 5 d of
differentiation. The array-CGH experiments were done with
independently derived primary cells. Array data were deposited in
GEO (GSE30636).
Fluorescence in Situ Hybridization and
Immunofluorescence staining
BAC clones were from RP-11 (http://www.chori.org/bacpac/)
libraries of the Welcome Trust Sanger Institute and cosmid clone
for CYP27B1 (LLNLc132M0263Q2) available from ImaGenes
GmbH, Germany.
BAC probes were directly labeled using High Prime Labeling
System (Roche Molecular Biochemicals, Germany). 1 mg of BAC-
DNA each were labeled with Cyanine-3-dCTP (Cy3) or Cyanine-
5-dCTP (Cy5) (PerkinElmer, Germany), according to the manu-
facturers instructions. 60 ng of Cy3-labeled and/or Cy5-labeled
probe DNA were precipitated in the presence of human Cot-1
DNA. Samples were resuspended in hybridization mix (50%
formamide, 26SSPE, 10% dextrane sulphate and 4% SDS).
NHNP sphere cells were grown on laminin-coated slides under
differentiation promoting conditions. Slides were washed once
with PBS and methanol fixed 10 min at 220uC. Slides were
treated for 5 min in 0.02% Tween-20/PBS.
For FISH with simultaneous immunofluorescence staining,
slides were RNase treated (100 mg/ml RNaseA in 26 SSC) for
15 minutes at 37uC. Postfixation was done by 1% formaldehyde/
16PBS for 10 minutes at room temperature. Slides were blocked
with goat serum and incubated for 1 h with antibodies either
chicken polyclonal to GFAP (ab4674, Abcam) or rabbit polyclonal
to neuron specific beta-III-Tubulin (ab18207, Abcam) and
detected using Alexa-488 coupled secondary antibodies. Finally,
slides were dehydrated by an ascending ethanol series (70%/80%/
96%) and air-dried.
For FISH without simultaneous immunofluorescence staining,
slides were RNase treated (100 mg/ml RNaseA in 26 SSC) for
30 minutes at 37uC and pepsin treated (0.005% in 0.01 M HCl at
37uC) for 10 minutes. Postfixation and dehydration was done as
described.
Both immune fluorescence analyses with and without FISH
were done in biological replicates with primary cell cultures that
were independently derived from human embryonic brain.
Hybridization
Labeled BAC probes were applied to the slides and denatured
for 2 min. at 80uC. Hybridization was done in a humid chamber
at 37uC for 16 h. Post hybridization washes were performed in
50% formamide/26SSPE (465 minutes; 45uC) followed by 0.16
SSPE (365 minutes) at 60uC. Nuclei were counterstained with
DAPI (49,69-Diamidino-2-phenylindole) (1 mg/ml in PBS) for
4 minutes and mounted with VectaShield mounting medium
Figure 4. FISH and immunofluorescence analysis. FISH with GINS2 specific BAC (pink) and simultaneous immunofluorescence staining with
GFAP (green) revealed GINS2 amplification in cells with beginning GFAP expression after 5 d of differentiation (A). FISH with CDK4 specific BAC (pink)
and immunofluorescence staining with GFAP revealed CDK4 amplification in cells with beginning GFAP expression after 2 d of differentiation (B). FISH
with CDK4 specific BAC (pink) and immunofluorescence staining with Tubulin-ß-III-chain (green) revealed CDK4 amplification in cells with beginning
Tubulin-ß-III-chain expression after 11 d of differentiation (C and D). Nuclei were counterstained with DAPI. Size calibration bar=5 mm.
doi:10.1371/journal.pone.0037422.g004
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analysis.
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